| |
Latest 10 SEC filings (by transaction date) for URGN within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 20/24 | Mar 18/24 | Schoenberg Mark | Direct Ownership | Ordinary Shares | S - Open market or private sale | -12,000 | $14.05 |
Feb 5/24 | Feb 1/24 | Smith Jason Drew | Direct Ownership | Ordinary Shares | S - Open market or private sale | -3,328 | $15.78 |
Feb 5/24 | Feb 1/24 | Smith Jason Drew | Direct Ownership | Ordinary Shares | S - Open market or private sale | -1,248 | $15.78 |
Feb 5/24 | Feb 1/24 | Smith Jason Drew | Direct Ownership | Ordinary Shares | S - Open market or private sale | -417 | $15.78 |
Feb 5/24 | Feb 1/24 | Schoenberg Mark | Direct Ownership | Ordinary Shares | S - Open market or private sale | -1,894 | $15.78 |
Feb 5/24 | Feb 1/24 | Schoenberg Mark | Direct Ownership | Ordinary Shares | S - Open market or private sale | -758 | $15.78 |
Feb 5/24 | Feb 1/24 | Schoenberg Mark | Direct Ownership | Ordinary Shares | S - Open market or private sale | -1,137 | $15.78 |
Feb 12/24 | Jan 31/24 | Kim Dong | Direct Ownership | Ordinary Shares | M - Exercise or conversion exempt under rule 16b-3 | 3,333 | |
Feb 2/24 | Jan 31/24 | Smith Jason Drew | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -6,666 | |
Feb 2/24 | Jan 31/24 | Smith Jason Drew | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -2,500 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for URGN within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 20/24 | Mar 18/24 | Schoenberg Mark | Direct Ownership | Ordinary Shares | S - Open market or private sale | -12,000 | $14.05 |
Feb 12/24 | Jan 31/24 | Kim Dong | Direct Ownership | Ordinary Shares | M - Exercise or conversion exempt under rule 16b-3 | 3,333 | |
Feb 12/24 | Mar 25/22 | Kim Dong | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 20,000 | |
Feb 5/24 | Feb 1/24 | Smith Jason Drew | Direct Ownership | Ordinary Shares | S - Open market or private sale | -3,328 | $15.78 |
Feb 5/24 | Feb 1/24 | Smith Jason Drew | Direct Ownership | Ordinary Shares | S - Open market or private sale | -1,248 | $15.78 |
Feb 5/24 | Feb 1/24 | Smith Jason Drew | Direct Ownership | Ordinary Shares | S - Open market or private sale | -417 | $15.78 |
Feb 5/24 | Feb 1/24 | Schoenberg Mark | Direct Ownership | Ordinary Shares | S - Open market or private sale | -1,894 | $15.78 |
Feb 5/24 | Feb 1/24 | Schoenberg Mark | Direct Ownership | Ordinary Shares | S - Open market or private sale | -758 | $15.78 |
Feb 5/24 | Feb 1/24 | Schoenberg Mark | Direct Ownership | Ordinary Shares | S - Open market or private sale | -1,137 | $15.78 |
Feb 2/24 | Jan 31/24 | Smith Jason Drew | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -6,666 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |